Adenosine diphosphatase and activators thereof and their...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/46 (2006.01) A61P 7/02 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2368099

The present invention relates to materials and methods for the diagnosis and treatment of pre-eclampsia and related conditions characterised by platelet aggregation. In particular it relates to the use of adenosine diphosphatase (ADPase) and activators of ADPase for the treatment of pre-eclampsia, in order to overcome the inhibition of ADPase by inositol phosphoglycans (IPGs). Also provided is a method for screening for compounds with ADPase-stimulatory activity in the presence or absence of IPGs.

La présente invention concerne des matériaux et des procédés pour diagnostiquer et traiter la pré-éclampsie et les pathologies associées caractérisées par l'agrégation plaquettaire. Elle concerne, en particulier, l'utilisation d'adénosine diphosphatase (ADPase) et d'activateurs d'ADPase pour le traitement de la pré-éclampsie, de manière à surmonter l'inhibition de l'ADPase par inositolphosphoglycane (IPG). L'invention porte également sur un procédé de criblage de composés présentant une activité de stimulation d'ADPase en présence ou en l'absence d'IPG.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adenosine diphosphatase and activators thereof and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenosine diphosphatase and activators thereof and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine diphosphatase and activators thereof and their... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1604125

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.